CCM
CAAS Capital Management Portfolio holdings
AUM
$211M
This Quarter Return
+7.73%
1 Year Return
+0.26%
3 Year Return
-2.04%
5 Year Return
+39.32%
10 Year Return
–
AUM
$3.1B
AUM Growth
+$3.1B
(+88%)
Cap. Flow
+$1.18B
Cap. Flow
% of AUM
37.9%
Top 10 Holdings %
Top 10 Hldgs %
29.87%
Holding
707
New
311
Increased
31
Reduced
42
Closed
140
Top Buys
| 1 |
Royalty Pharma
RPRX
|
$180M |
| 2 |
Sunrun
RUN
|
$105M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$88.3M |
| 4 |
Dynatrace
DT
|
$73.2M |
| 5 |
fuboTV
FUBO
|
$69.1M |
Top Sells
| 1 |
First Solar
FSLR
|
$81.9M |
| 2 |
Denali Therapeutics
DNLI
|
$73.5M |
| 3 |
Caesars Entertainment
CZR
|
$72.1M |
| 4 |
10x Genomics
TXG
|
$62.3M |
| 5 |
Alibaba
BABA
|
$43.1M |
Sector Composition
| 1 | Technology | 23.7% |
| 2 | Healthcare | 21.13% |
| 3 | Communication Services | 9.14% |
| 4 | Consumer Discretionary | 6.99% |
| 5 | Financials | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELL
51
DELISTED
PhenomeX Inc. Common Stock
CELL
| $15.5M | 0.15% |
173,061
+158,061
| +1,054% | +$14.1M |
|
|
52
Denali Therapeutics
DNLI
$2.24B
| $15.1M | 0.14% |
180,463
-877,908
| -83% | -$73.5M |
|
53
KKR & Co
KKR
$120B
| $14.7M | 0.14% |
+363,315
| New | +$14.7M |
|
54
Option Care Health
OPCH
$4.7B
| $13.7M | 0.13% |
+875,139
| New | +$13.7M |
|
55
Envista
NVST
$3.37B
| $13.3M | 0.13% |
+395,580
| New | +$13.3M |
|
56
Intel
INTC
$105B
| $13.3M | 0.13% |
267,500
+173,500
| +185% | +$8.64M |
|
57
New Fortress Energy
NFE
$631M
| $13.3M | 0.13% |
+248,326
| New | +$13.3M |
|
58
Lumentum
LITE
$9.37B
| $12.5M | 0.12% |
+132,158
| New | +$12.5M |
|
|
HZAC
59
DELISTED
Horizon Acquisition Corporation
HZAC
| $12.5M | 0.12% |
+1,250,000
| New | +$12.5M |
|
|
FBC
60
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $12.4M | 0.12% |
304,502
+55,302
| +22% | +$2.25M |
|
|
CD
61
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $12M | 0.11% |
501,500
-200,000
| -29% | -$4.79M |
|
62
Advanced Micro Devices
AMD
$263B
| $11.8M | 0.11% |
+128,700
| New | +$11.8M |
|
|
RETA
63
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $11.8M | 0.11% |
+95,288
| New | +$11.8M |
|
|
ALXN
64
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.6M | 0.11% |
+74,500
| New | +$11.6M |
|
65
Sprout Social
SPT
$896M
| $11.2M | 0.11% |
+246,643
| New | +$11.2M |
|
66
Leslie's
LESL
$60.9M
| $11.1M | 0.11% |
+400,000
| New | +$11.1M |
|
|
DRNA
67
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $10.8M | 0.1% |
+489,765
| New | +$10.8M |
|
68
Adaptive Biotechnologies
ADPT
$1.96B
| $10.7M | 0.1% |
+180,431
| New | +$10.7M |
|
69
Butterfly Network
BFLY
$378M
| $10.6M | 0.1% |
+537,311
| New | +$10.6M |
|
70
Kymera Therapeutics
KYMR
$3.1B
| $10.5M | 0.1% |
169,771
+144,251
| +565% | +$8.94M |
|
71
American Well
AMWL
$112M
| $10.1M | 0.1% |
400,000
| – | – |
|
72
Mastercard
MA
$536B
| $10M | 0.1% |
+28,098
| New | +$10M |
|
73
Intuit
INTU
$187B
| $10M | 0.1% |
+26,398
| New | +$10M |
|
74
Nkarta
NKTX
$149M
| $10M | 0.1% |
+162,905
| New | +$10M |
|
|
SWTX
75
DELISTED
SpringWorks Therapeutics
SWTX
| $9.76M | 0.09% |
+134,522
| New | +$9.76M |
|